Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up study

Draganov, Peter V.; Chauhan, Shailendra S.; Wagh, Mihir S.; Gupte, Anand; Lin, Ting‐Tse; Hou, Wei; Forsmark, Chris E.

doi:10.1016/j.gie.2011.09.020

Cited by 232 publications

(177 citation statements)

References 21 publications

(24 reference statements)

Supporting

Mentioning

163

Contrasting

Unclassified

Order By: Relevance

“…It is now accepted that the SpyBite® forceps has the ability to gather material for histological analysis in most situations, ranging from 82% to 97% [3,19]. The lower specificity in the earlier study (82%) was driven by biopsy results that were inadequate for a histologic interpretation on an intention to treat (ITT) analysis.…”

Section: Diagnostic Applicationsmentioning

confidence: 94%

“…Cholangioscopy using the SpyGlass® with a SpyBite® forceps can potentially overcome this deficiency, allowing the evaluation of the mucosa and biopsies be obtained under direct visualization. Sensitivity of SpyBite® biopsy forceps is much greater for intrinsic (66%) than for extrinsic (8%) malignant lesions [19]. On the other hand, the sensitivity of SpyGlass® visual impression alone was less severely compromised by extrinsic (62%) than intrinsic (84%) lesions.…”

Section: Diagnostic Applicationsmentioning

confidence: 96%

“…The lower specificity in the earlier study (82%) was driven by biopsy results that were inadequate for a histologic interpretation on an intention to treat (ITT) analysis. In a prospective study conducted by Navaneethan et al, the authors compared SpyBite® forceps biopsies with standard cytology brushings and standard forceps biopsies [19]. Sample quality was considered adequate in 96% of brushing forceps biopsies.…”

Section: Diagnostic Applicationsmentioning

confidence: 99%

See 2 more Smart Citations

Peroral Cholangiopancreatoscopy with the SpyGlass® System: What do we Know 10 Years Later

Pereira

Peixoto

Andrade

et al. 2017

JGLD

View full text Add to dashboard Cite

Smaller endoscopes and catheters have been developed that permit direct visualization of the bile and pancreatic ducts (cholangioscopy and pancreatoscopy, respectively). These endoscopes and catheters are passed through the working channel of a standard therapeutic duodenoscope during endoscopic retrograde cholangiopancreatography (ERCP). The SpyGlass Direct Visualization System (Boston Scientific Corp, Natick, MA, USA) is currently the most widely used and studied device. Cholangioscopy with intraductal lithotripsy has become an established modality in the treatment of difficult biliary lithiasis. When used in the evaluation of indeterminate biliary strictures by experienced endoscopists in recognizing intraductal pathology, it increases the diagnostic yield of tissue sampling. Pancreatoscopy is complementary to other imaging modalities in the evaluation of intraductal papillary mucinous neoplasms of the pancreas and is emerging as a sole or adjunctive therapy to extracorporeal shock wave lithotripsy for the treatment of main pancreatic duct stones. It remains investigational in the diagnosis of pancreatic adenocarcinoma. Complications specific to the performance of cholangiopancreatoscopy include cholangitis, which is related to intraductal fluid irrigation.Abbreviations: EHL: Electrohydraulic lithotripsy; ERCP: Endoscopic retrograde cholangiopancreatography; ESWL: Extracorporeal lithotripsy by shock waves; ET: Endoscopic therapy; EUS: Endoscopic ultrasound; IPMN: intraductal papillary mucinous neoplasm; LL: Laser lithotripsy; MDCT: Multi-detector computed conventional tomography; MPD: Main pancreatic duct; MRCP: Magnetic resonance cholangiopancreatography; MRI: Magnetic resonance imaging; POCPS: Peroral cholangiopancreatoscopy; PSC: Primary sclerosing cholangitis

show abstract

Section: Diagnostic Applicationsmentioning

confidence: 94%

Section: Diagnostic Applicationsmentioning

confidence: 96%

Section: Diagnostic Applicationsmentioning

confidence: 99%

See 1 more Smart Citation

Peroral Cholangiopancreatoscopy with the SpyGlass® System: What do we Know 10 Years Later

Pereira

Peixoto

Andrade

et al. 2017

JGLD

View full text Add to dashboard Cite

show abstract

“…Overall, the diagnostic accuracy, sensitivity and specificity of POCS-guided biopsies has been shown to be 72%-85%, 49%-82%, and almost 100%, respectively. [92][93][94] POCS can increase the yield of ERCP in the assessment of the longitudinal extension of PCC and DCC. The prospective study of 43 patients with CC showed that POCS had accuracy of 82% and 92% for diagnosing longitudinal extension of CC on the hepatic side (to the second order bile ducts) and papillary side (intrapancreatic common bile duct) respectively.…”

Section: Per-oral Cholangioscopymentioning

confidence: 99%

Comprehensive management of cholangiocarcinoma: Part I. Diagnosis

Papafragkakis

Lee

2017

Int J Gastrointest Interv

View full text Add to dashboard Cite

A B S T R A C TCholangiocarcinoma is the second most common primary hepatic malignancy and its incidence is increasing worldwide. Classification and staging of intrahepatic, perihilar, and distal cholangiocarcinomas provide useful prognostic information and further guide in their management. Establishing diagnosis is frequently challenging and may require a multi-modality approach that includes advanced radiological imaging studies and procedures for tissue acquisition; the endoscopic procedures that have been utilized in the management of cholangiocarcinoma comprise endoscopic retrograde cholangiopancreatography with brushing and biopsy, endoscopic ultrasound-guided fine needle aspiration, cholangioscopy with targeted biopsy, and intraductal confocal endomicroscopy. In this review, we will examine the strengths and limitations of each diagnostic tool and assess the serum and bile tumor markers.

show abstract

“…In this sense, periampullary forceps biopsy (and cytology) should be added in cases with biliary stricture, as this method has high sensitivity for confirming cancer tissue in the biliary cancer cases (77% [69,70] -92% [71] ).…”

Section: Exclusion Of the Pancreatobiliary Malignanciesmentioning

confidence: 99%

Diagnosis Autoimmune Pancreatitis

Hart¹,

Chari²

The Pancreapedia: Exocrine Pancreas Knowledge Base

View full text Add to dashboard Cite

Autoimmune pancreatitis (AIP) is a distinct form of chronic pancreatitis that is increasingly being reported. The presentation and clinical image findings of AIP sometimes resemble those of several pancreatic malignancies, but the therapeutic strategy differs appreciably. Therefore, accurate diagnosis is necessary for cases of AIP. To date, AIP is classified into two distinct subtypes from the viewpoints of etiology, serum markers, histology, other organ involvements, and frequency of relapse: type 1 is related to IgG4 (lymphoplasmacytic sclerosing pancreatitis) and type 2 is related to a granulocytic epithelial lesion (idiopathic duct-centric chronic pancreatitis). Both types of AIP are characterized by focal or diffuse pancreatic enlargement accompanied with a narrowing of the main pancreatic duct, and both show dramatic responses to corticosteroid. Unlike type 2, type 1 is characteristically associated with increasing levels of serum IgG4 and positive serum autoantibodies, abundant infiltration of IgG4-positive plasmacytes, frequent extrapancreatic lesions, and relapse. These findings have led several countries to propose diagnostic criteria for AIP, which consist of essentially similar diagnostic items; however, several differences exist for each country, mainly due to differences in the definition of AIP and the modalities used to diagnose this disease. An attempt to unite the diagnostic criteria worldwide was made with the publication in 2011 of the international consensus diagnostic criteria for AIP, established at the 2010 Congress of the International Association of Pancreatology (IAP).

show abstract

Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up study

Cited by 232 publications

References 21 publications

Peroral Cholangiopancreatoscopy with the SpyGlass® System: What do we Know 10 Years Later

Peroral Cholangiopancreatoscopy with the SpyGlass® System: What do we Know 10 Years Later

Comprehensive management of cholangiocarcinoma: Part I. Diagnosis

Diagnosis Autoimmune Pancreatitis

Contact Info

Product

Resources

About